Latest Cover
Welcome to Progress in Neurology and Psychiatry’s dedicated website. Progress is for health professionals in secondary and primary care looking after patients with neurological and psychiatric diseases. If you are a health professional working in the field of neurology or psychiatry you can register with us for free access to our content.Sign up for e-alerts and print copies

Latest News

Many learning disability services thorough in care and prescribing

Concern over the level of prescribing in people with learning disabilities is not warranted, says Chief Pharmacist Carol Paton at the Royal College of...Read more

Interpersonal problems drive prescribing

Interpersonal problems may drive prescribing for the treatment of borderline personality disorder (BPD), and antidepressants are an ineffective treatment for...Read more

Biobank data used in new research

Data from the UK Biobank is now being used to discover the causes of psychiatric illness.A session at the Royal College of Psychiatrists International Congress...Read more

New smartphone app may prevent suicides

A new smartphone app may have the potential to prevent suicides and identify patients at high risk.The app, developed by researchers at Harvard University,...Read more

MS drug approved

The European Medicines Agency has granted marketing authorisation for daclizumab (ZINBRYTA), the once-monthly treatment for relapsing multiple...Read more

Featured Articles

Antidepressant drug interactions: evidence and clinical significance
Antidepressants are widely used in the general population, primarily to treat depression but also commonly in conditions such as anxiety disorders and neuropathic pain. This article considers the significant pharmacodynamic and pharmacokinetic drug interactions of different antidepressants…
Click here to view

Clozapine-induced neutropenia reversed by lithium
Clozapine is effective in treating refractory cases of schizophrenia and schizoaffective disorder, however, it can induce the serious side-effect of neutropenia. There is an evolving evidence base in which lithium…
Click here to view

Factors important to psychiatrists when prescribing depot antipsychotics
The relative benefits and disadvantages of first-generation antipsychotics (FGAs) and second-generation antipsychotics (SGAs) has been an area of much interest since SGAs were introduced amidst high expectations of superior efficacy and improved side-effect profiles.
Click here to view

Web design and marketing agency Leamington Spa